Based on PubMed | Can endometrial cancer cause a skin rash in its early stages, and how common is this compared with other early symptoms?

Endometrial cancer and early skin rash: what to know

• In early-stage endometrial cancer, a skin rash is not a typical or expected symptom. The most common early warning sign is abnormal vaginal bleeding, such as bleeding after menopause or bleeding between periods. ^[1] Pelvic pain and watery or blood‑tinged vaginal discharge can occur, but they are less common early signs compared with bleeding. ^[1] Public health guidance also highlights abnormal vaginal bleeding or discharge as key symptoms to watch for. ^{[2] [3]}

• A true skin rash related directly to the cancer itself is rare, especially at presentation. Skin findings in endometrial cancer more often reflect treatment side effects (for example, rashes with chemotherapy or immunotherapy) or extremely uncommon paraneoplastic skin syndromes or cutaneous metastases, which typically occur with advanced or recurrent disease rather than stage I. ^{[4] [5] [6]}

Typical early symptoms

• Abnormal uterine bleeding: The single most frequent early symptom, particularly postmenopausal bleeding. ^[1] Even a small amount of bleeding after menopause should be assessed because it can be an early sign of endometrial cancer. ^[7]
• Bleeding between periods (in those not yet menopausal). ^[1]
• Watery or bloody vaginal discharge and sometimes pelvic pain, although pain is more often seen as disease advances. ^{[1] [7]}
• Clinical reviews consistently note that postmenopausal bleeding is the most common presenting symptom, and most cases are diagnosed at an early stage because bleeding prompts evaluation. ^{[8] [9]}

How common is rash compared with early bleeding or discharge?

• Rash frequency: There is no evidence that simple “skin rash” is a common presenting sign of early (stage I) endometrial cancer. Paraneoplastic skin conditions (like acanthosis nigricans, “tripe palms,” or acquired hypertrichosis lanuginosa) are rare and usually signal advanced or recurrent disease rather than an initial early-stage presentation. ^[5] Cutaneous metastasis from endometrial cancer is also very rare (reported prevalence around 1% or less) and indicates widespread disease with a poor prognosis, not an early-stage finding. ^[6]
• Bleeding/discharge frequency: In contrast, abnormal vaginal bleeding is the predominant early symptom and the reason most early-stage cases are detected, with pelvic pain and discharge occurring less frequently at presentation. ^{[1] [8] [9]}

Bottom line

• Skin rash is not considered an early symptom of endometrial cancer, whereas abnormal vaginal bleeding is the most common early sign. ^{[1] [8]} Rashes are far more likely to be unrelated to the cancer itself, or they may occur later in the course due to treatment or rare paraneoplastic syndromes. ^{[4] [5]}

---

Rare skin manifestations in context

• Paraneoplastic dermatoses: These are uncommon skin changes that can accompany some cancers; in endometrial cancer, reported cases are few and are typically associated with progression or recurrence rather than initial diagnosis. ^[5]

• Cutaneous metastases: Extremely uncommon in endometrial cancer and usually signal advanced systemic spread; they are not a hallmark of early disease. ^[6]

• Treatment-related rashes: When endometrial cancer requires chemotherapy, targeted therapy, or immunotherapy, skin rashes are a known side effect profile, which can include red, bumpy, dry, or itchy rashes, peeling, or blisters. ^[4]

---

What to do if you’re concerned

• Seek evaluation for any abnormal vaginal bleeding or postmenopausal spotting, as this is the most reliable early warning sign and warrants prompt assessment. ^{[1] [7]}
• If you develop a new skin rash while on cancer treatment, inform your care team, since therapy adjustments or supportive care may be needed. ^[4]
• If there is a sudden onset of unusual skin changes (for example, widespread velvety darkening of skin folds or rapid hair growth of fine hair) without another explanation, it is reasonable to discuss this with a clinician, although such paraneoplastic signs are rare and not typical of early-stage disease. ^[5]

---

Quick comparison table

Feature	Early-stage endometrial cancer	Notes
Abnormal vaginal bleeding (postmenopausal or between periods)	Common, most frequent early sign	Prompts early detection and evaluation. [1] [7] [8]
Vaginal discharge (watery or blood‑tinged)	Can occur early, less common than bleeding	May accompany or follow bleeding. [1]
Pelvic pain	Less common early; more typical as disease advances	Pain tends to increase with later stage. [7]
Skin rash (directly due to cancer)	Very rare in early disease	Paraneoplastic rashes are uncommon and usually reflect progression or recurrence. [5]
Cutaneous metastasis	Extremely rare; indicates advanced disease	Prevalence reported under ~1%; poor prognosis. [6]
Treatment-related rash	Not a presenting sign; can occur during therapy	Seen with chemotherapy/immunotherapy. [4]

---

Key takeaways

• Early-stage endometrial cancer almost always presents with abnormal vaginal bleeding rather than skin rash. ^{[1] [8]}
• Skin rashes are rarely a direct sign of early endometrial cancer and are more commonly related to treatments or very uncommon paraneoplastic syndromes/skin metastases in advanced settings. ^{[4] [5] [6]}